Evidence map›Paper›PMID 28895938›Full record

ArticleBiomolecules2017

Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils.

Megan Garvey, Heath Ecroyd, Nicholas J Ray, Juliet A Gerrard, John A Carver

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The multifaceted nature of αB-crystallin.Cell stress & chaperones · 2020
    Review
  8. Article
  9. A new era for understanding amyloid structures and disease.Nature reviews. Molecular cell biology · 2018
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Megan GarveyCSL Limited, 45 Poplar Road, Parkville, VIC 3052, Australia. megan.garvey@csl.com.au.
Heath EcroydSchool of Biological Sciences and the Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong NSW 2522, Australia. heathe@uow.edu.au.
Nicholas J RayResearch School of Chemistry, The Australian National University, Acton ACT 2601, Australia. nicholas.ray@anu.edu.au.
Juliet A GerrardSchool of Biological Science and School of Chemical Science, University of Auckland, Auckland 1010, New Zealand. j.gerrard@auckland.ac.nz.
John A CarverResearch School of Chemistry, The Australian National University, Acton ACT 2601, Australia. john.carver@anu.edu.au.
Australian National University · AUCSL (Australia) · AUIllawarra Health and Medical Research Institute · AUUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid fibril formation occurs from a wide range of peptides and proteins and is typically associated with a loss of protein function and/or a gain of toxic function, as the native structure of the protein undergoes major alteration to form a cross β-sheet array. It is now well recognised that some amyloid fibrils have a biological function, which has led to increased interest in the potential that these so-called functional amyloids may either retain the function of the native protein, or gain function upon adopting a fibrillar structure. Herein, we investigate the molecular chaperone ability of α-crystallin, the predominant eye lens protein which is composed of two related subunits αA- and αB-crystallin, and its capacity to retain and even enhance its chaperone activity after forming aggregate structures under conditions of thermal and chemical stress. We demonstrate that both eye lens α-crystallin and αB-crystallin (which is also found extensively outside the lens) retain, to a significant degree, their molecular chaperone activity under conditions of structural change, including after formation into amyloid fibrils and amorphous aggregates. The results can be related directly to the effects of aging on the structure and chaperone function of α-crystallin in the eye lens, particularly its ability to prevent crystallin protein aggregation and hence lens opacification associated with cataract formation.

Indexed as

alpha-Crystallin A Chainalpha-Crystallin B ChainAmyloidAnimalsCattleHumansLens, CrystallineMolecular ChaperonesProtein AggregatesProtein BindingProtein FoldingProtein Structure, TertiaryProtein Unfoldingalpha-Crystallin A Chainalpha-Crystallin B ChainAmyloidMolecular ChaperonesProtein Aggregatesamyloid fibrilmolecular chaperoneprotein aggregationprotein unfoldingsmall heat-shock protein

Identifiers

PMID28895938
PMCPMC5618248
OpenAlexW2755512213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.